Alemtuzumab achieved durable hematologic response in heavily treated t-large granular lymphocytosis irrespective to STAT3 mutation or v-beta clone size

This article has no abstract
Epistemonikos ID: ad93a814d10f87d7e20458535f78b61be3046be6
First added on: Feb 05, 2025